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Type IV P-type ATPases (P4-ATPases) translocate phospholipids from the exoplasmic to the 
cytoplasmic leaflets of cellular membranes. We and others previously showed that ATP11C, a 
member of P4-ATPases, translocates phosphatidylserine (PS) at the plasma membrane. Twenty 
years ago, the UPS-1 (uptake of fluorescent PS analogs) cell line was isolated from mutagenized 
Chinese hamster ovary (CHO)-K1 cells with a defect in non-endocytic uptake of NBD-PS. Due 
to its defect in PS uptake, the UPS-1 cell line has been used in an assay for PS-flipping activity; 
however, the gene(s) responsible for the defect have not been identified to date. Here, we found 
that the mRNA level of ATP11C was dramatically reduced in UPS-1 cells relative to parental 
CHO-K1 cells. By contrast, the level of ATP11A, another PS-flipping P4-ATPase at the plasma 
membrane, or CDC50A, which is essential for delivery of most P4-ATPases to the plasma 
membrane, was not affected in UPS-1 cells. Importantly, we identified a nonsense mutation in the 
ATP11C gene in UPS-1 cells, indicating that the intact ATP11C protein is not expressed. 
Moreover, exogenous expression of ATP11C can restore PS uptake in UPS-1 cells. These results 
indicate that lack of the functional ATP11C protein is responsible for the defect in PS uptake in 
UPS-1 cells and ATP11C is crucial for PS-flipping in CHO-K1 cells. 
 




The lipid bilayers of cellular membranes exhibit asymmetric lipid distributions. In the 
plasma membrane, the aminophospholipids, phosphatidylserine (PS) and 
phosphatidylethanolamine (PE), are abundant in the cytoplasmic leaflet, whereas 
phosphatidylcholine (PC) and sphingomyelin (SM) are enriched in the exoplasmic leaflet. Type 
IV P-type ATPases (P4-ATPases) are essential for generation and maintenance of phospholipid 
asymmetry in lipid bilayers (1,2). Regulated exposure of PS in the exoplasmic leaflet is critical 
for certain biological processes, including apoptotic cell death, platelet coagulation, and fusion of 
muscle cells, (3-5) illustrating the importance of lipid asymmetry at steady state. Most mammalian 
and yeast P4-ATPases must associate with CDC50 family proteins in order to exit the endoplasmic 
reticulum (ER) and reach their appropriate subcellular destinations (6-12). We recently showed 
that the human P4-ATPases, ATP11A, and ATP11C, flip NBD-labeled PS (NBD-PS) and NBD-
PE, whereas ATP8B1, ATP8B2, and ATP10A flip NBD-PC specifically at the plasma membrane 
(13,14). Phospholipid asymmetry regulated by P4-ATPases is indispensable for homeostasis of 
multicellular organisms. Mutations in the human FIC1/ATP8B1 gene cause progressive familial 
intrahepatic cholestasis (PFIC) (15,16). Some ATP8B1 mutants found in type 1 PFIC fail to flip 
PC, indicating that PC-flipping activity at the bile canaliculi is critical for proper bile excretion in 
liver (13). ATP11C deficiency causes a defect in B-cell maturation, altered erythrocyte shape, and 
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anemia (17,18). Moreover, ATP11C undergoes caspase-mediated cleavage and is consequently 
inactivated, resulting in PS exposure on the cell surface during apoptosis (19).  
UPS-1 (uptake of fluorescent PS analogs) cells were isolated by screening mutants of CHO-
K1 cells defective in non-endocytic uptake of NBD-PS (20), and have been widely used in an 
assay for PS-flipping activity due to their defect in PS uptake (8,9,16,21,22). However, the gene(s) 
responsible for the defect have not been previously identified. In this study, we found that the 
expression level of ATP11C mRNA was substantially decreased in UPS-1 cells, whereas the level 
of ATP11A or CDC50A mRNA was not affected. Importantly, we found a nonsense mutation in 
the ATP11C gene in UPS-1 cells. We further demonstrated that uptake of PS was restored upon 
exogenous expression of ATP11C in UPS-1 cells. These results indicate that the defect in PS 
uptake in UPS-1 cells is ascribed to the lack of the functional ATP11C protein. 
 
Materials and Methods 
Plasmids. P4-ATPase cDNAs were cloned separately into the pENTR3C vector (Invitrogen), as 
described previously (12).  
 
RT-PCR and quantitative RT- PCR (qRT-PCR). Total RNA was isolated from CHO or UPS-1 cells 
using Isogen (Nippon Gene) or RNeasy Mini Kit (Qiagen), and then subjected to RT-PCR analysis 
5 
 
using the SuperScript III One-Step RT-PCR system (Invitrogen). For qRT-PCR, total RNA was 
subjected to reverse transcription using a SuperScript VILO cDNA Synthesis Kit (Invitrogen). The 
resultant cDNA was used as a template for PCR using LightCycler FastStart DNA MasterPLUS SYBR 
Green I (Roche Applied Science); fold changes in gene expression were normalized to the -actin 
mRNA level. Chinese hamster ATP11C cDNA was amplified using the following primer pairs: set 1 
(sense, 5’-ATACTGAGCTCTTAGAACTGACC-3’; antisense, 5’-
ATCACTATTCCTGGCTGCTTGG-3’), set 2 (sense, 5’-GAACAGCACATCAACGTTGATAC-3’; 
antisense, 5’-CTGATAAATATGAGGAGAATTATGG-3’) and set 3 (3’UTR; sense, 5’-
GTATAGGGTTCAGAATAAATGTCC-3’; antisense, 5’-GATATTAGACCAAGACAATTAGTC-3’). 
The ATP11A, CDC50A, and-actin cDNAs were amplified using the primer pairs (sense, 5’-
CATGGAAGTGCTCAAGAGAGAC-3’; antisense, 5’-GAGCAGGCTGACAGTGACAAG-3’), 
(sense, 5’-GCCAGTTAAATGGAGACCCTAG-3’; antisense, 5’-
GTCCAGCTGGTAATGTTGGATG-3’), and (sense, 5’-CTGTATGCCTCTGGTCGTAC-3’; 
antisense, 5’-GCCATCTCCTGCTCGAAGTC-3’), respectively. 
 
Sequencing of ATP11C cDNA and its chromosomal gene in CHO-K1 and UPS-1 cells. Total 
RNA was isolated from UPS-1 cells using RNeasy Mini Kit (Qiagen). Nine fragments of ATP11C 
cDNA covering full length of ATP11C were amplified by RT-PCR, cloned into TA cloning vector 
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(BioDynamics Laboratory) and sequenced at least four independent clones of each fragment. Nine 
fragments of ATP11C cDNA was amplified using the following primer pairs: F1 (5’-
ATGTCGTGTGCTGGAGAAGAG-3’; 5’-CTCGGAGGTTATCAATGGATTC-3’), F2  (5’-
CAGCCAGTCTTGATGGTGAATC-3’; 5’-CCATCAACTTCCTGAGTAGTGC-3’), F3 (5’-
CAGATAAGACTGGAACACTCAC-3’; 5’-GTAAGCACCCAGACTTTCAAGC-3’), F4 (5’-
GGAGCCACTGCTGTGGAAGAC-3’; 5’-GTAAGCAGCATCATAAAGTGGC-3’), F5 (5’-
CAATATTTCTTCTATAAGAACCTTTG-3’; 5’-CTTTAGCTGCAATCAGAGTCAATATG-3’), 
F6 (5’-CAGATAAGACTGGAACACTCAC-3’; 5’-GATTTGGCTGTTTCCATCTTGTC-3’) , F7 
(5’-CAGCCAGTCTTGATGGTGAATC-3’; 5’-GTAAGCACCCAGACTTTCAAGC-3’), F8 
(5’-CAGATAAGACTGGAACACTCAC-3’; 5’-GTAAGCAGCATCATAAAGTGGC-3’), F9 
(5’-CAATATTTCTTCTATAAGAACCTTTG-3’; 5’-CTGTTACATTATATTAGATTCGTCTG-
3’). Genomic DNA was prepared from CHO-K1 and UPS-1 cells using Isogen (Nippon Gene) and 
362 bp DNA fragment carrying the exon 19 and its 5’ intron region was amplified by PCR with 
following primers: 5’-CAGAGACAGCACAACTCTGATAAG-3’; 5’-
CACTCAGCAACTTCTTACGATATTC-3’. The PCR products were purified and sequenced with 
a primer of 5’-GAATTGCTAGTGAGCTATAAGGATG-3’ and analyzed with an ABI PRIZM 




Antibodies and reagents. The sources of antibodies used in the present study were as follows: 
monoclonal rabbit anti-Sodium Potassium ATPase (Na/K-ATPase), Abcam; monoclonal rat anti-
HA (3F10), Roche Applied Science; monoclonal mouse anti–-tubulin, Millipore; Cy3- and 
horseradish peroxidase–conjugated secondary antibodies, Jackson ImmunoResearch 
Laboratories; Alexa Fluor 488-conjugated secondary antibody, Invitrogen. The NBD-labeled 




phosphocholine), and NBD-SM (N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-
sphingosine-1-phosphocholine).  
 
Cell culture, establishment of stable cell lines, and Immunofluorescence Analysis. UPS-1 (20) 
cells and parental CHO-K1 cells were grown in a 1:1 mixture of Dulbecco’s modified Eagle’s 
medium and Ham’s F-12 medium supplemented with 10% fetal calf serum, 2.5 mM L-glutamine. 
UPS-1 cell line, originally established by Kentaro Hanada (National Institute of Infectious 
Diseases, Tokyo, Japan), was provided by the RIKEN BRC through the National Bio-Resource 
Project of the MEXT (Tsukuba, Japan). For retroviral production, pMXs-neo–derived vectors for 
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expression of HA-tagged P4-ATPases were co-transfected with pEF-gag-pol and pCMV-VSVG-
RSV-Rev into HEK293T cells. The pMXs-neo vectors and the pEF-gag-pol plasmid were kind 
gifts from Toshio Kitamura (The University of Tokyo, Tokyo, Japan). The pCMV-VSVG-RSV-
Rev plasmid was a kind gift from Hiroyuki Miyoshi (RIKEN BRC, Tsukuba, Japan). The resultant 
retroviruses were concentrated as described previously, (23) and then used to infect UPS-1 cells. 
For stable cell lines, the infected cells were selected in medium containing G418 (400 g/ml) and 
isolated as clones. A mixed population of retrovirus-infected cells or cloned stable cell lines were 
used for flippase assay, RT-PCR, and immunofluorescence analysis. Immunofluorescence 
staining was performed as described previously (24,25) and visualized using an Axiovert 
200MAT microscope (Carl Zeiss, Thornwood, NY). Briefly, cells were fixed, permeabilized and 
immunostained with anti-Sodium Potassium ATPase (Na/K-ATPase) and anti-HA (3F10) 
antibodies followed by Alexa Fluor 488–conjugated anti-rabbit and Cy3–conjugated anti-rat 
secondary antibodies. 
 
Flippase assay. Incorporation of NBD-phospholipids was analyzed by flow cytometry as 
described. (13) In brief, CHO-K1 or UPS-1 cells were detached from dishes in PBS containing 5 
mM EDTA, and then harvested by centrifugation. Cells (1 × 106 cells per sample) were washed 
and equilibrated at 15°C for 15 min in 500 l of Hank’s balanced salt solution (pH 7.4) containing 
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1 g/L glucose (HBSS-glucose). An equal volume of 2 M NBD-phospholipid in HBSS-glucose 
was added to the cell suspension and incubated at 15°C. At each time point, 200 L of cell 
suspension was collected and mixed with 200 L of ice-cold HBSS-glucose containing 5% fatty 
acid–free BSA (Wako Pure Chemical) in order to extract NBD-lipids incorporated into the 
exoplasmic leaflet of the plasma membrane, as well as unincorporated NBD-lipids. Next, 10,000 
cells were analyzed on a FACSCalibur flow cytometer (BD Biosciences) to measure fluorescence 
of NBD-lipids translocated into the cytoplasmic leaflet of the plasma membrane. Mean 
fluorescence intensities per cell were calculated. Propidium iodide–positive cells (i.e., dead cells) 
were excluded from the analysis.   
 
Results and Discussion 
A nonsense mutation is found in ATP11C gene in UPS-1 cells. 
UPS-1, a mutant cell line of CHO-K1 (hereafter CHO), is defective in non-endocytic uptake 
of NBD-PS (20). Prior to the experiments described below, we confirmed that the uptake of NBD-
PS is defective in UPS-1 cells. To this end, we assayed the flippase activities by incubating CHO 
and UPS-1 cells in the presence of NBD-PS, -PE, -PC, or -SM at 15°C, followed by extraction 
with fatty acid–free BSA of fluorescent phospholipids that were unincorporated or retained in the 
exoplasmic leaflet of the plasma membrane. As shown in Figure 1A and B, uptake of NBD-PS 
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was lower in UPS-1 cells than in parental CHO cells, whereas uptake of NBD-PE, -PC, or -SM 
did not change. These results are consistent with those of an original report (20).  
We recently elucidated flippase activities and substrate specificities of the plasma 
membrane–localized human P4-ATPases, ATP8B1, ATP8B2, ATP10A, ATP11A, and ATP11C, 
using NBD-labeled phospholipids. ATP11A and ATP11C translocate NBD-aminophospholipids 
(PS and PE), whereas ATP8B1, ATP8B2, and ATP10A preferentially flip NBD-PC (13,14). We 
also previously showed that CDC50A is required for the plasma membrane localization of 
ATP11A and ATP11C (12). Knockdown by RNAi or CRISPR/Cas9 knockout of CDC50A 
dramatically decreases PS-flipping activity in several cell types (our unpublished data) (19). 
Moreover, ATP11C deficiency also decreases PS-flipping activity (17-19). Therefore, we 
hypothesized that the defect in the uptake of PS in UPS-1 cells might result from a defect in 
plasma membrane-localizing PS-flipping P4-ATPases (ATP11A and ATP11C) or a defect in 
CDC50A, which is required for delivery of P4-ATPases to the plasma membrane. To examine 
this hypothesis, we firstly performed RT-PCR to measure the mRNA levels of ATP11A, ATP11C, 
and CDC50A in CHO and UPS-1 cells (Figure 2A). All primer sets were designed to include at 
least one predicted intron to avoid amplification from genomic DNA. As shown in Figure 2A, the 
mRNA level of ATP11C was substantially lower in UPS-1 cells (U) than in CHO cells (C). We 
confirmed the low level of ATP11C mRNA in UPS-1 cells using three independent primer sets 
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(Figures 2A and 4E). By contrast, the mRNA levels of ATP11A and CDC50A were comparable 
between UPS-1 and CHO cells (Figure 2A). We also examined the mRNA levels of ATP11A, 
ATP11C, and CDC50A by quantitative RT-PCR. As shown in Figure 2B, the mRNA level of 
ATP11C was much lower in UPS-1 cells than in the parental CHO cells. By contrast, the ATP11A 
and CDC50A mRNA levels in UPS-1 cells were comparable to those in CHO cells.  
Next, we examined a possibility that the coding sequence of ATP11C is changed in UPS-1 
cells. To this end, we cloned nine cDNA fragments for ATP11C from UPS-1, which altogether 
cover the entire coding sequence of ATP11C and its C-terminal splicing variant, and sequenced 
at least four independent clones for each fragment. Interestingly, we found a nonsense mutation 
in the region covered by exon 19 (Figure 2C). Direct sequencing of a chromosomal DNA region 
(362 bp) encompassing exon 19 and the preceding intron indicated that the ATP11C gene in UPS-
1 cells carried a G to A homozygous mutation in exon 19, resulting in a change in the Trp664 
codon (TGG) to a nonsense codon (TGA) (Figure 2C and D). Although chromosomal 
heterogeneity has been observed in CHO cell lines (26,27), the raw data of direct sequencing of 
the chromosomal DNA showed a single peak at the mutation site (Figure 2C), indicating a 
homozygous mutation in the ATP11C gene. We cannot exclude a possibility that the locus of 
ATP11C gene in UPS-1 cells is hemizygous. These results indicate that the defect of PS-uptake 
in UPS-1 cells is caused by the lack of the functional ATP11C protein, although we could not 
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examine the ATP11C protein level because an antibody, which can detect endogenous ATP11C in 
CHO cells, is not available. 
The mutation site was located at 205 nucleotides upstream from the junction between exon 
19 and exon 20 (Figure 2C). Nonsense-mediated mRNA decay (NMD) is a well-characterized 
posttranscriptional quality control mechanism to ensure transcription fidelity (28). NMD can be 
activated when a nonsense codon appears over 50-55 nucleotides upstream from an exon-exon 
junction. Thus, in UPS-1 cells, the ATP11C mRNA might be degraded by the NMD mechanism 
and thus the level of ATP11C was dramatically reduced (Figure 2A and B).  
We previously showed that expression of ATP11A and ATP11C in HeLa cells increases the 
PS- and PE-flipping activities, although the PE-flipping activity of ATP11C is lower than that of 
ATP11A(13). Because PE-flipping activity was not significantly affected in UPS-1 cells (Figure 
1A and B), ATP11C is primarily responsible for PS-flipping in CHO cells. The residual PS-
flipping activity observed in UPS-1 cells might be due to the presence of ATP11A, or other 
flipping activities (Figure 1A). ATP11C appears to be a critical protein for PS-flipping at the 
plasma membrane in multiple cell types; 1) some phenotypes of the ATP11C mutant mice cannot 
be suppressed by the presence of endogenous ATP11A (17,18) and 2) degradation of ATP11C by 





Exogenous expression of ATP11C complements the defect in PS-flipping activity in UPS-1 
cells. 
Next, we asked whether PS-flipping activity can be recovered by exogenous expression of 
ATP11C in UPS-1 cells. To this end, we expressed C-terminally HA-tagged ATP11C or its 
ATPase-deficient Glu-to-Gln mutant (E184Q) (13) by infection of recombinant retrovirus, and 
subjected the infected cells to the flippase assay. ATP11C and the ATP11C(E184Q) mutant were 
expressed at comparable levels, as confirmed by immunoblot analysis (Figure 3C). By expressing 
ATP11C but not ATP11C(E184Q), the PS-flipping activity was significantly increased, relative 
to vector-infected UPS-1 cells (Figure 3A and B), whereas the PE-flipping activity was not 
changed. When a UPS-1 cell line stably expressing ATP11C was examined (clone 16), PS-
flipping activity was approximating to that in parental CHO cells (Figure 4A and B). We 
confirmed ATP11C expression in clone 16 by immunoblot analysis (Figure 4C) and its 
localization to the plasma membrane (PM) by immunofluorescence (Figure 4D). Thus, in CHO 
cells, ATP11C is crucial for PS-flipping, but not PE-flipping. Because there was a subtle, but 
significant, increase in the PE-flipping activity in stably ATP11C-expressing UPS-1 cells (Figure 
4A), exogenous ATP11C may also flip NBD-PE as we described previously (13).  
In order to exclude possible contamination of parental CHO cells in the ATP11C-expressing 
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UPS-1 cells, we performed RT-PCR analysis using a set of primers targeting the 3’-untranslated 
region of the Chinese hamster ATP11C. The endogenous mRNA level of ATP11C did not change 
among the exogenous ATP11C- or ATP11C(E184Q)-expressing UPS-1 cells (Figure 3H). Thus, 
the recovery of PS-flipping activity in UPS-1 cells is due to the exogenous expression of ATP11C 
rather than contamination of parental CHO cells.  
Based on these results, we conclude that the defect in PS uptake observed in UPS-1 cells is 
ascribed to the lack of functional ATP11C. It is likely that ATP11C is a major P4-ATPase involved 
in PS-flipping in CHO cells. ATP11C-deficient mice exhibit anemia, hyperbilirubinemia, 
abnormal differentiation of B cells, and hepatocellular carcinoma (17,18,29). Hopefully, UPS-1 
cells will be useful for understanding the physiological and pathophysiological roles of ATP11C.  
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Figure 1 UPS-1 cells have a defect in NBD-PS uptake. 
(A, B) Parental CHO-K1 (CHO) and UPS-1 cells were incubated with the indicated NBD-lipids 
at 15°C for 10 min (NBD-PS) or 15 min (NBD-PE, NBD-PC, or NBD-SM). After extraction with 
fatty acid–free BSA, the residual fluorescence intensity associated with the cells was determined 
by flow cytometry. (A) Graphs are averages of three independent experiments ± SD. (B) 
Histogram of a representative experiment displaying the differences in fluorescence intensity 
between CHO (solid lines) and UPS-1 (dashed lines) cells. 
 
Figure 2 Reduced expression and mutation of ATP11C in UPS-1 cells. 
(A) RT-PCR was performed using total RNA isolated from CHO (C) and UPS-1 (U) cells. Two 
different primer sets for ATP11C were designed. (×25, 25 cycles; ×30, 30 cycles; ×35, 35 cycles) 
(B) qRT-PCR results from two independent experiments (averages are shown). (C) Genomic PCR 
analysis of ATP11C. A region encompassing exon 19 and a preceding intron (362 bp) was 
amplified using a primer set (blue arrows) for genomic DNA from CHO (C) and UPS-1 (U) cells. 
The arrowhead indicates the position of the amplified genomic PCR product (362 bp). Direct 
sequencing data indicate the presence of a homozygous point mutation (G to A) in the ATP11C 
gene in UPS-1 cells. (D) Schematic representation of the ATP11C protein and the position of the 
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nonsense mutation found in UPS-1 cells. 
 
Figure 3 Exogenous expression of human ATP11C (WT) but not ATP11C(E184Q) rescued PS-
flipping activity in UPS-1 cells. 
(A) UPS-1 cells (-) infected with empty retrovirus vector (vector) or recombinant virus vector 
encoding HA-tagged ATP11C(WT) or ATP11C(E184Q) were incubated with the indicated NBD-
lipids at 15°C for 15 min (10 min for NBD-PS). After extraction with fatty acid–free BSA, the 
residual fluorescence intensity associated with the cells was determined by flow cytometry. 
Graphs show the results from three independent experiments (averages ± SD). (B) Histogram of 
a representative experiment showing the differences in fluorescence intensity among UPS-1 
(dashed lines), UPS-1 infected with empty retrovirus vector (gray lines), or UPS-1 infected with 
retrovirus vector encoding ATP11C (blue lines) or ATP11C(E184Q) (red lines) in the presence of 
the indicated NBD-lipids. (C) Expression levels of ATP11C and ATP11C(E184Q) in UPS-1 cells 
were analyzed by immunoblotting with antibodies against HA and -tubulin (as an internal 
control).  
 
Figure 4 Stable expression of ATP11C in UPS-1 cells restored PS-flipping activity comparable 
to parental CHO cells. 
23 
 
(A) An ATP11C-expressing UPS-1 cell line (clone 16) was isolated. The flippase activities of 
CHO, UPS-1, and UPS-1(clone16) cells were measured as described in Figure 3A. Graphs are 
averages of four independent experiments ± SD. (B) Histogram of a representative experiment 
showing the differences in the fluorescence intensity among CHO (solid lines), UPS-1 (dashed 
lines), and an ATP11C-expressing UPS-1 cell line (clone 16) (blue lines) in the presence of the 
indicated NBD-lipids. (C) Expression level of ATP11C in UPS-1 cells (clone 16) was analyzed 
by immunoblotting with antibodies against HA and -tubulin (as an internal control). (D) Cells 
were fixed, permeabilized and immunostained with antibody against Na/K-ATPase (a marker for 
the plasma membrane, PM) and anti-HA antibody followed by Alexa488–conjugated anti-rabbit 
and Cy3–conjugated anti-rat antibodies, respectively. Bar, 10 m. (E) RT-PCR was performed 
using total RNA isolated from indicated cells. A primer set targeting the 3’UTR of the Chinese 
hamster ATP11C was designed.  
 




